Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organismsJames A. Retsema, Rachel J. Mason, Agnès Girard et al.|Antimicrobial Agents and Chemotherapy|1987Cited by 461
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distributionAgnès Girard, James A. Retsema, D Girard et al.|Antimicrobial Agents and Chemotherapy|1987Cited by 323
Sulbactam/Ampicillin: In Vitro Spectrum, Potency, and Activity in Models of Acute InfectionJames A. Retsema, Perry S. Sawyer, L. A. Brennan et al.|Clinical Infectious Diseases|1986Cited by 106
CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and BacteroidesJames A. Retsema, Agnès Girard, A. R. English|Antimicrobial Agents and Chemotherapy|1980Cited by 82
Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivoJames A. Retsema, William B. Milisen, D Girard et al.|Journal of Antimicrobial Chemotherapy|1990Cited by 74